OLIGOMERIX

Chemical products and compositions intended for medical research, namely, reagents, chemical entities and compounds; chemical preparations for scientific purposes, chemical reagents or products for laboratory analyses for monitoring, analyzing and identifying diagnostic targets and therapeutic products, and for conducting research in connection with pharmaceutical sciences; chemical preparations intended for scientific purposes, namely, for leading research in connection with pharmaceutical sciences

Pharmaceutical products for the treatment of diseases, namely, Alzheimer's disease and other neurodegenerative diseases; reagents for diagnostic purposes and diagnostic media intended for medical purposes, namely, reagents and media intended for tests, namely, tests based on blood biomarkers for identifying patients affected by diseases or those at risk of developing a disease and for identifying patients responding to specific personalized treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; biopharmaceutical products, namely, reagents, chemical entities and compounds for diagnosing, preventing and treating diseases, namely, Alzheimer's disease and other neurodegenerative diseases; chemical preparations for medical and pharmaceutical purposes, namely, chemicals for diagnosing Alzheimer's disease and other neurodegenerative diseases, especially chemical preparations for diagnosing diseases in the nature of neurodegenerative diseases

Research and development of pharmaceutical molecules, compounds, inhibitors, antibodies and biological markers for diagnostic purposes and medicines for treating diseases; research and development of new products and preparations for the treatment of Alzheimer's disease and other neurodegenerative diseases; research and development in the field of pharmaceutical drugs; biological research; biotechnological research; technical research in the field of biotechnology; consultancy in the field of biotechnology